唐贝克是格列吡嗪的特殊剂型(格列吡嗪缓释胶囊),与其它磺脲类药物相比,其特点为高效、长效、用药量少、不良反应少等,为大多数2型糖尿病患者所接受。为了进一步评价其对2型糖尿病的降糖疗效,自2003年5月~2005年5月对64例2型糖尿病人进行了12周的唐贝克疗效观察,现总结报告如下 Tang Becker is a special form of glipizide (glipizide sustained-release capsules), compared with other sulfonylureas, which is characterized by high efficiency, long-lasting, less dosage, fewer adverse reactions, the majority of 2 Type of diabetes patients accepted. To further evaluate its hypoglycemic effect on type 2 diabetes, 64 patients with type 2 diabetes mellitus underwent 12-week follow-up of Don Becker’s efficacy from May 2003 to May 2005. The summary report is as follows